- Home
- RLMD vs ABVC Comparison
RLMD vs ABVC Comparison
Compare RLMD & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- ABVC
- Stock Information
- Founded
- RLMD 2004
- ABVC 2015
- Country
- RLMD United States
- ABVC United States
- Employees
- RLMD N/A
- ABVC N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- RLMD Health Care
- ABVC Health Care
- Exchange
- RLMD Nasdaq
- ABVC Nasdaq
- Market Cap
- RLMD 11.5M
- ABVC 9.9M
- IPO Year
- RLMD N/A
- ABVC N/A
- Fundamental
- Price
- RLMD $0.30
- ABVC $0.70
- Analyst Decision
- RLMD Hold
- ABVC
- Analyst Count
- RLMD 4
- ABVC 0
- Target Price
- RLMD $4.25
- ABVC N/A
- AVG Volume (30 Days)
- RLMD 2.1M
- ABVC 1.2M
- Earning Date
- RLMD 03-18-2025
- ABVC 03-12-2025
- Dividend Yield
- RLMD N/A
- ABVC N/A
- EPS Growth
- RLMD N/A
- ABVC N/A
- EPS
- RLMD N/A
- ABVC N/A
- Revenue
- RLMD N/A
- ABVC $509,788.00
- Revenue This Year
- RLMD N/A
- ABVC N/A
- Revenue Next Year
- RLMD N/A
- ABVC N/A
- P/E Ratio
- RLMD N/A
- ABVC N/A
- Revenue Growth
- RLMD N/A
- ABVC N/A
- 52 Week Low
- RLMD $0.28
- ABVC $0.40
- 52 Week High
- RLMD $7.22
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- RLMD 30.81
- ABVC 75.66
- Support Level
- RLMD $0.28
- ABVC $0.40
- Resistance Level
- RLMD $0.36
- ABVC $0.88
- Average True Range (ATR)
- RLMD 0.04
- ABVC 0.08
- MACD
- RLMD 0.02
- ABVC 0.02
- Stochastic Oscillator
- RLMD 7.21
- ABVC 62.42
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.